Quest Diagnostics Inc Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31)
Quest Diagnostics Inc (DGX) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) of $210.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-04-27.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease · last filed 2012-04-27
- Quest Diagnostics Inc other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $210.00K.
- Quest Diagnostics Inc other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $210.00K, a 16.02% increase year-over-year.
- Quest Diagnostics Inc other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $209.00K, a 15.47% increase year-over-year.
- Quest Diagnostics Inc other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-06-30 was $210.00K, a 16.02% increase year-over-year.
- Quest Diagnostics Inc other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for fiscal 2011 was -$1.04M, a 243.92% decline from fiscal 2010.
- Quest Diagnostics Inc other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for fiscal 2010 was $724.00K.
- Quest Diagnostics Inc other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for fiscal 2009 was -$2.55M.
- Quest Diagnostics Inc other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for fiscal 2008 was -$784.00K.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | $210.00K 10-Q · filed 2012-04-27 | $420.00K derived: sum of 2 quarters · filed 2012-04-27 | $629.00K derived: sum of 3 quarters · filed 2012-04-27 | $839.00K derived: sum of 4 quarters · filed 2012-04-27 |
| 2011-12-31 | $210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | $419.00K derived: sum of 2 quarters · filed 2012-02-16 | $629.00K derived: sum of 3 quarters · filed 2012-02-16 | -$1.04M 10-K · filed 2012-02-16 |
| 2011-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $419.00K derived: sum of 2 quarters · filed 2011-11-03 | -$1.25M 10-Q · filed 2011-11-03 | -$1.07M derived: sum of 4 quarters · filed 2012-04-27 |
| 2011-06-30 | $210.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | -$1.46M 10-Q · filed 2011-07-27 | -$1.28M derived: sum of 3 quarters · filed 2012-04-27 | -$1.10M derived: sum of 4 quarters · filed 2012-04-27 |
| 2011-03-31 | -$1.67M 10-Q · filed 2012-04-27 | -$1.49M derived: sum of 2 quarters · filed 2012-04-27 | -$1.31M derived: sum of 3 quarters · filed 2012-04-27 | -$1.13M derived: sum of 4 quarters · filed 2012-04-27 |
| 2010-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | $362.00K derived: sum of 2 quarters · filed 2012-02-16 | $543.00K derived: sum of 3 quarters · filed 2012-02-16 | $724.00K 10-K · filed 2012-02-16 |
| 2010-09-30 | $181.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $362.00K derived: sum of 2 quarters · filed 2011-11-03 | $543.00K 10-Q · filed 2011-11-03 | $3.15M derived: sum of 4 quarters · filed 2012-02-16 |
| 2010-06-30 | $181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | $362.00K 10-Q · filed 2011-07-27 | $2.97M derived: sum of 3 quarters · filed 2012-02-16 | -$3.42M derived: sum of 4 quarters · filed 2012-02-16 |
| 2010-03-31 | $181.00K 10-Q · filed 2011-05-10 | $2.79M derived: sum of 2 quarters · filed 2012-02-16 | -$3.61M derived: sum of 3 quarters · filed 2012-02-16 | |
| 2009-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-16 | -$3.79M derived: sum of 2 quarters · filed 2012-02-16 | -$2.55M 10-K · filed 2012-02-16 | |
| 2009-09-30 | -$6.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | -$5.16M 10-Q · filed 2010-10-26 | ||
| 2009-06-30 | $1.23M 10-Q · filed 2010-07-27 | |||
| 2008-12-31 | -$784.00K 10-K · filed 2011-02-16 | |||
| 2007-12-31 | -$6.24M 10-K · filed 2010-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |